Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy

Objective. To study the effect of immunosuppressive therapy based on a reduction in standard dosages and target values of tacrolimus concentrations on the results of the postoperative period in recipients with a transplanted kidney. Materials and methods. The study included 176 kidney recipients who...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Parabina, O. V. Fatenkov, M. N. Myakotnykh, A. A. Mironov, A. G. Dodonov
Format: Article
Language:Russian
Published: Open Systems Publication 2023-10-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/1114
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693097683845120
author E. V. Parabina
O. V. Fatenkov
M. N. Myakotnykh
A. A. Mironov
A. G. Dodonov
author_facet E. V. Parabina
O. V. Fatenkov
M. N. Myakotnykh
A. A. Mironov
A. G. Dodonov
author_sort E. V. Parabina
collection DOAJ
description Objective. To study the effect of immunosuppressive therapy based on a reduction in standard dosages and target values of tacrolimus concentrations on the results of the postoperative period in recipients with a transplanted kidney. Materials and methods. The study included 176 kidney recipients who are under outpatient supervision of a nephrologist at the Samara Center for Organ and Tissue Transplantation. In accordance with the purpose and objectives of the study, the recipients were divided into two groups. The first group (control) included 78 patients receiving standard immunosuppressive therapy with calcineurin inhibitors (tacrolimus prolonged action) in combination with standard dosages of mycophenolic acid. The target concentration of tacrolimus in this group was 7-8 ng/ml. The second group (the main one) included 98 patients who received immunosuppressive therapy according to the tacrolimus prolonged action scheme in reduced dosages in combination with mycophenolic acid. The target concentration of tacrolimus in this group was 5-6 ng/ml. Both groups were comparable by gender, age, type and duration of stay on renal replacement therapy, as well as by the main diagnosis that led to chronic kidney disease.Results. In the course of the study, it was revealed that the minimization of IST leads to an improvement in the long-term results of transplantation. In the late postoperative period, in the group with reduced doses and target values of tacrolimus concentration, the creatinine level remained significantly lower than in the control subgroup. There was also a significant difference in the glomerular filtration rate – in the study group it was significantly higher by 20% than in the control group. A decrease in the target concentrations of tacrolimus in the postoperative period significantly led to a decrease in the frequency of dose-dependent side effects, which subsequently led to a significant improvement in the quality of life of recipients in the control group.
format Article
id doaj-art-61cfe2fbbda74f30aeabcb28e188aebb
institution DOAJ
issn 1560-5175
2687-1181
language Russian
publishDate 2023-10-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-61cfe2fbbda74f30aeabcb28e188aebb2025-08-20T03:20:31ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812023-10-0109152110.51793/OS.2023.26.9.0021107Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapyE. V. Parabina0O. V. Fatenkov1M. N. Myakotnykh2A. A. Mironov3A. G. Dodonov4Federal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Health of the Russian FederationFederal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Health of the Russian FederationFederal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Health of the Russian FederationFederal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Health of the Russian FederationFederal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Health of the Russian FederationObjective. To study the effect of immunosuppressive therapy based on a reduction in standard dosages and target values of tacrolimus concentrations on the results of the postoperative period in recipients with a transplanted kidney. Materials and methods. The study included 176 kidney recipients who are under outpatient supervision of a nephrologist at the Samara Center for Organ and Tissue Transplantation. In accordance with the purpose and objectives of the study, the recipients were divided into two groups. The first group (control) included 78 patients receiving standard immunosuppressive therapy with calcineurin inhibitors (tacrolimus prolonged action) in combination with standard dosages of mycophenolic acid. The target concentration of tacrolimus in this group was 7-8 ng/ml. The second group (the main one) included 98 patients who received immunosuppressive therapy according to the tacrolimus prolonged action scheme in reduced dosages in combination with mycophenolic acid. The target concentration of tacrolimus in this group was 5-6 ng/ml. Both groups were comparable by gender, age, type and duration of stay on renal replacement therapy, as well as by the main diagnosis that led to chronic kidney disease.Results. In the course of the study, it was revealed that the minimization of IST leads to an improvement in the long-term results of transplantation. In the late postoperative period, in the group with reduced doses and target values of tacrolimus concentration, the creatinine level remained significantly lower than in the control subgroup. There was also a significant difference in the glomerular filtration rate – in the study group it was significantly higher by 20% than in the control group. A decrease in the target concentrations of tacrolimus in the postoperative period significantly led to a decrease in the frequency of dose-dependent side effects, which subsequently led to a significant improvement in the quality of life of recipients in the control group.https://journal.lvrach.ru/jour/article/view/1114kidney transplantationimmunosuppressive therapytacrolimuschronic kidney disease
spellingShingle E. V. Parabina
O. V. Fatenkov
M. N. Myakotnykh
A. A. Mironov
A. G. Dodonov
Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
Лечащий Врач
kidney transplantation
immunosuppressive therapy
tacrolimus
chronic kidney disease
title Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
title_full Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
title_fullStr Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
title_full_unstemmed Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
title_short Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
title_sort evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
topic kidney transplantation
immunosuppressive therapy
tacrolimus
chronic kidney disease
url https://journal.lvrach.ru/jour/article/view/1114
work_keys_str_mv AT evparabina evaluationoftheresultsoftreatmentofkidneyrecipientsattheoutpatientstageagainstthebackgroundofminimizingimmunosuppressivetherapy
AT ovfatenkov evaluationoftheresultsoftreatmentofkidneyrecipientsattheoutpatientstageagainstthebackgroundofminimizingimmunosuppressivetherapy
AT mnmyakotnykh evaluationoftheresultsoftreatmentofkidneyrecipientsattheoutpatientstageagainstthebackgroundofminimizingimmunosuppressivetherapy
AT aamironov evaluationoftheresultsoftreatmentofkidneyrecipientsattheoutpatientstageagainstthebackgroundofminimizingimmunosuppressivetherapy
AT agdodonov evaluationoftheresultsoftreatmentofkidneyrecipientsattheoutpatientstageagainstthebackgroundofminimizingimmunosuppressivetherapy